CDK9 is a cyclin dependent kinase and an essential regulator of cancer-promoting transcriptional programs
Potentially Best-in-Class Selectivity
Potential to avoid off-target toxicity and higher clinical activity
About
A seasoned team experienced in developing cancer medicines to create a fully integrated oncology company.